Spectral Medical Inc. (TSX:EDT)

Revenue by Product

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Exclusive Rights Distribution	668.00K
Exclusive Rights Distribution Growth	0%
Proprietary Biochemicals	428.00K
Proprietary Biochemicals Growth	21.59%
Endotoxin Activity Assay Diagnostic	239.00K
Endotoxin Activity Assay Diagnostic Growth	-39.34%
Royalties	126.00K
Royalties Growth	-23.17%
Clinical Research Services	74.00K
Instrumentation	63.00K
Instrumentation Growth	-29.21%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	1.02M
United States Growth	10.30%
Italy	246.00K
Italy Growth	-21.66%
Ireland	245.00K
Ireland Growth	218.18%
Other	90.00K
Other Growth	-71.79%